Evidence map›Paper›PMID 36300112›Full record

ArticleFrontiers in immunology2022

The role of mitochondria in the pathogenesis of Kawasaki disease.

Mikayla A Beckley, Sadeep Shrestha, Keshav K Singh, Michael A Portman

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mikayla A BeckleyCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, United States.
Sadeep ShresthaDepartment of Epidemiology, School of Public Health University of Alabama at Birmingham, Birmingham, AL, United States.
Keshav K SinghDepartment of Genetics, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Michael A PortmanCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, United States.
University of Alabama at Birmingham · USUniversity of Washington · US

Funding

Genetic Prediction for Treatment Resistance in Kawasaki DiseaseR01HL146130 · NHLBI · SEATTLE CHILDREN'S HOSPITAL · PI PORTMAN, MICHAEL A, SHRESTHA, SADEEP · 2019 to 2022
$3.6M
NHLBI NIH HHS R01 HL146130
6 · The paper itself

Abstract

Kawasaki disease is a systemic vasculitis, especially of the coronary arteries, affecting children. Despite extensive research, much is still unknown about the principal driver behind the amplified inflammatory response. We propose mitochondria may play a critical role. Mitochondria serve as a central hub, influencing energy generation, cell proliferation, and bioenergetics. Regulation of these biological processes, however, comes at a price. Release of mitochondrial DNA into the cytoplasm acts as damage-associated molecular patterns, initiating the development of inflammation. As a source of reactive oxygen species, they facilitate activation of the NLRP3 inflammasome. Kawasaki disease involves many of these inflammatory pathways. Progressive mitochondrial dysfunction alters the activity of immune cells and may play a role in the pathogenesis of Kawasaki disease. Because they contain their own genome, mitochondria are susceptible to mutation which can propagate their dysfunction and immunostimulatory potential. Population-specific variants in mitochondrial DNA have also been linked to racial disparities in disease risk and treatment response. Our objective is to critically examine the current literature of mitochondria's role in coordinating proinflammatory signaling pathways, focusing on potential mitochondrial dysfunction in Kawasaki disease. No association between impaired mitochondrial function and Kawasaki disease exists, but we suggest a relationship between the two. We hypothesize a framework of mitochondrial determinants that may contribute to ethnic/racial disparities in the progression of Kawasaki disease.

Indexed as

InflammasomesMucocutaneous Lymph Node SyndromeChildDisease SusceptibilityDNA, MitochondrialHumansMitochondriaNLR Family, Pyrin Domain-Containing 3 ProteinReactive Oxygen SpeciesDNA, MitochondrialInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinReactive Oxygen SpeciesinflammasomeinflammationKawasaki diseasemitochondriamitochondrial DNAmitophagyreactive oxygen species

Identifiers

PMID36300112
PMCPMC9592088
OpenAlexW4303969211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.